netFormulary
 Report : A-Z HCD items in Formulary 16/11/2019 23:17:58
[Back]
 
Section Status CCG Name
13.05 Restricted Use CCG Dupilumab Dupixent
13.05.03 Restricted Use CCG Risankizumab Skyrizi
01.05 Restricted Use CCG Tofacitinib XELJANZ
10.01.03 Restricted Use CCG Tofacitinib XELJANZ
Leicestershire Health Community